Scilex Holding Co

Scilex Holding Co has a negative net equity of -$207.8 million and a current ratio of 0.08, indicating significant liquidity constraints. The company's cash and equivalents amount to only $4.96 million, while its long-term debt stands at $117.7 million. The enterprise value to revenue ratio is 5.55, which is relatively high for a company with negative operating and net income.

The company's profitability is severely challenged, with a net loss of $358.7 million and an operating loss of $353.4 million. Return on equity is 1.73%, and return on assets is -9.83%, both of which are well below industry norms. The gross profit margin is 65.0%, but this is insufficient to offset the high operating expenses.

Scilex's revenue is concentrated in a single business segment, with no disclosed geographic diversification. The company does not provide segment-specific revenue breakdowns, making it difficult to assess the contribution of different therapeutic areas or markets to overall performance.

The company's growth trajectory is negative, with a net loss and declining cash flow. Free cash flow is -$429.95 million, and capital expenditures are -$16.77 million. Analysts have recorded a revenue of $30.25 million and an EPS of -$32.97, reflecting the company's financial distress.

The risk assessment indicates medium liquidity risk and low dilution risk. The company's negative net cash position after subtracting total debt is a key flag. The dilution potential is low, but the company's financial instability could lead to future equity offerings.

Recent financial filings and transcripts show a continued focus on cost management and debt restructuring. The company has not disclosed any major new product launches or partnerships that could significantly alter its financial trajectory.

Scilex Holding Co (SCLX.O) has recorded a notable addition to its shareholder base, marking the first analysis for this ticker. As of March 31, 2026, investor ID 931 acquired a position of 752 shares, valued at approximately $0.00482 million. This transaction represents a weight of roughly 0.0000023% of the company's equity, detected on June 20, 2026. This activity is significant as it establishes the initial baseline for tracking ownership changes in Scilex Holding Co. With no prior basis for delta computation, this entry serves as the starting point for monitoring future holder dynamics. The company currently reports nine top holders, providing context for the scale of this new position relative to the broader ownership structure. The firm operates with zero analyst coverage and no index memberships, indicating limited institutional scrutiny and market integration at this stage. Additionally, the company lists zero officers in the current dataset, suggesting a minimal disclosed executive footprint or data availability. These structural factors highlight the early-stage or niche nature of the entity's public profile. Given the absence of cross-source signals or material changes beyond this initial holder update, the primary focus remains on the establishment of this ownership record. The lack of analyst estimates or financial history in the immediate context underscores the importance of this first data point for future comparative analysis. Investors should monitor subsequent filings for further developments in ownership or corporate structure.